1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Recurrent Cutaneous Melanoma: new trials by email Literature Review of Recurrent Cutaneous Melanoma trials Research Report on Recurrent Cutaneous Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma Ibrutinib, Laboratory Biomarker Analysis, Pharmacogenomic Study - Metastatic Melanoma, Recurrent Cutaneous Melanoma | Phase 2 | Completed | National Cancer Institute (NCI) | 18 | 2016-12-16 | 2026-08-11 |
Melanoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Skin Diseases (1) · Skin Neoplasms (1) · Skin and Connective Tissue Diseases (1)
Pharmacogenomic Testing (1) · ibrutinib (1)
National Cancer Institute (NCI) (1)
United States (1)
UM1CA186644 (1), UM1CA186686 (1), UM1CA186688 (1), UM1CA186689 (1), UM1CA186690 (1), UM1CA186691 (1), UM1CA186704 (1), UM1CA186709 (1), UM1CA186712 (1), UM1CA186716 (1), UM1CA186717 (1)